Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/10/2003WO2002065127A9 A system and method for characterizing the permittivity of molecular events
04/10/2003WO2002063013A3 Human acid phosphatase gene
04/10/2003WO2002062958A3 Prc17: an amplified cancer gene
04/10/2003WO2002062201A3 Rare event detection system
04/10/2003WO2002059311A3 Colon cancer marker
04/10/2003WO2002059280A3 Chronic lymphocytic leukemia cell line and its use for producing an antibody
04/10/2003WO2002057460A3 Polynucleotides encoding human phosphatases
04/10/2003WO2002055705A3 Proteins and nucleic acids encoding same
04/10/2003WO2002050285A9 Histone deacetylase-related gene and protein
04/10/2003WO2002050122A3 Means for the diagnosis and therapy of ctcl
04/10/2003WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments
04/10/2003WO2002048338A3 Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
04/10/2003WO2002046757A3 High throughput determination of antigen expression
04/10/2003WO2002046406A3 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
04/10/2003WO2002042842A3 A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels
04/10/2003WO2002042414A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
04/10/2003WO2002040674A3 '67118', '67067' and '62092', human proteins and methods of use thereof
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002022852A3 Method for measuring antithrombin activity
04/10/2003WO2002016643A8 Dna pooling methods for quantitative traits using unrelated populations or sib pairs
04/10/2003WO2002012544A3 Identification of short chain dehydrogenases/reductases (sdr)
04/10/2003WO2002008965A3 Method for determining spatial distances in polymers
04/10/2003WO2002008396A3 Human proteases
04/10/2003WO2001073014A9 Human survivin interacting protein 1 (sip-1)
04/10/2003WO2001068923A3 Mitochondrial dosimeter
04/10/2003WO2000018968A8 An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase
04/10/2003US20030070184 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
04/10/2003US20030069703 Method and system for detection of hydrocarbon species in a gas
04/10/2003US20030069702 Method and apparatus for hemostasis and blood management
04/10/2003US20030069701 DNA chip technique for identifying multiple kinds of DNA contained in a target
04/10/2003US20030069700 Fab fragment crystal containing BC2 complementarity determining regions (CDRs).
04/10/2003US20030069699 Device for drug-drug interaction testing sample preparation
04/10/2003US20030069698 Method and system for predicting pharmacokinetic properties
04/10/2003US20030069509 Devices for physiological fluid sampling and methods of using the same
04/10/2003US20030069489 Method and apparatus for signal transmission and detection using a contact device
04/10/2003US20030069445 Biological reagents and methods for determining the mechanism in the generation of beta-amyloid peptide
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069405 70 human secreted proteins
04/10/2003US20030069403 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069398 Identification of human gaba transporter
04/10/2003US20030069395 Serum albumin conjugate for use in the transfer and delivery of therapeutic agent to target
04/10/2003US20030069394 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069313 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
04/10/2003US20030069264 Method of determining and reducing the risk of bph-related urologic events
04/10/2003US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/10/2003US20030069246 Central nervous system disorders; psychological disorders; cardiovascular disorders
04/10/2003US20030069231 Purification of antibodies; Elisa analyzing; antidiabetic agents; skin disorders; cardiovascular agents
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
04/10/2003US20030069199 Treatment methods based on microcompetition for a limiting GABP complex
04/10/2003US20030069198 Materials and methods related to the inflammatory effects of secreted amyloid precursor proteins
04/10/2003US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression.
04/10/2003US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities
04/10/2003US20030069179 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069178 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068831 Proteins and druggable regions of proteins
04/10/2003US20030068830 Determining the concentration of glycated proteinin sample; obtain sample, incubate with solid support, expose to buffer, determine concentration of bound protein
04/10/2003US20030068825 System and method of determining proteomic differences
04/10/2003US20030068822 Generation of calibration tool for use in the analysis of synthetic blood; obtain blood substitute, cross link, use as control in monitoring quality of blood product
04/10/2003US20030068807 Precursor conversion screening methods
04/10/2003US20030068806 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
04/10/2003US20030068802 Use of streptococcus pneumoniae acyl carrier protein synthase crystal structure in diagnostics, antimicrobial drug design, and biosensors
04/10/2003US20030068798 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068797 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068796 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068795 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068794 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068775 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068774 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068773 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068772 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068768 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068767 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068766 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068764 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068763 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068762 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068761 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068759 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068758 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068757 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068756 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068755 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068754 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068753 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068752 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068751 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068750 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068749 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068748 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068747 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068746 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068745 Secreted and transmembrane polypeptides and nucleic acids encoding the same